Literature DB >> 9499406

Interaction of recombinant Tetrahymena telomerase proteins p80 and p95 with telomerase RNA and telomeric DNA substrates.

L Gandhi1, K Collins.   

Abstract

Telomerase is a specialized reverse transcriptase that catalyzes telomeric repeat addition at the ends of existing telomeres or fragmented chromosomes. Two telomerase proteins from Tetrahymena thermophila, p80 and p95, were identified on the basis of their association with telomerase activity and telomerase RNA. Here we have produced recombinant versions of these proteins to characterize their functions in the ribonucleoprotein. Our findings indicate that the two proteins can form a complex whose association is independent of RNA. Each protein interacts directly with telomerase RNA, but the p80/p95 complex binds RNA with an affinity substantially greater than either protein alone. We have also characterized the DNA binding properties of p95 and show that it interacts with telomeric substrate DNAs with a specificity characteristic of the functionally defined Tetrahymena telomerase substrate anchor site. Together, these findings suggest a model in which protein-nucleic acid interactions separable from the active site contribute to positioning the template and primer, rather than exclusively the direct nucleic acid-active site interaction typical of other polymerases.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9499406      PMCID: PMC316588          DOI: 10.1101/gad.12.5.721

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  47 in total

1.  Telomerase catalytic subunit homologs from fission yeast and human.

Authors:  T M Nakamura; G B Morin; K B Chapman; S L Weinrich; W H Andrews; J Lingner; C B Harley; T R Cech
Journal:  Science       Date:  1997-08-15       Impact factor: 47.728

2.  The catalytic subunit of yeast telomerase.

Authors:  C M Counter; M Meyerson; E N Eaton; R A Weinberg
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-19       Impact factor: 11.205

3.  A mutant with a defect in telomere elongation leads to senescence in yeast.

Authors:  V Lundblad; J W Szostak
Journal:  Cell       Date:  1989-05-19       Impact factor: 41.582

4.  In vivo alteration of telomere sequences and senescence caused by mutated Tetrahymena telomerase RNAs.

Authors:  G L Yu; J D Bradley; L D Attardi; E H Blackburn
Journal:  Nature       Date:  1990-03-08       Impact factor: 49.962

5.  Telomerase primer specificity and chromosome healing.

Authors:  L A Harrington; C W Greider
Journal:  Nature       Date:  1991-10-03       Impact factor: 49.962

6.  De novo telomere addition by Tetrahymena telomerase in vitro.

Authors:  H Wang; E H Blackburn
Journal:  EMBO J       Date:  1997-02-17       Impact factor: 11.598

7.  Codon usage in Tetrahymena and other ciliates.

Authors:  D W Martindale
Journal:  J Protozool       Date:  1989 Jan-Feb

8.  hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization.

Authors:  M Meyerson; C M Counter; E N Eaton; L W Ellisen; P Steiner; S D Caddle; L Ziaugra; R L Beijersbergen; M J Davidoff; Q Liu; S Bacchetti; D A Haber; R A Weinberg
Journal:  Cell       Date:  1997-08-22       Impact factor: 41.582

9.  Use of polymerase chain reaction for the rapid construction of synthetic genes.

Authors:  P J Dillon; C A Rosen
Journal:  Methods Mol Biol       Date:  1993

10.  TLP1: a gene encoding a protein component of mammalian telomerase is a novel member of WD repeats family.

Authors:  J Nakayama; M Saito; H Nakamura; A Matsuura; F Ishikawa
Journal:  Cell       Date:  1997-03-21       Impact factor: 41.582

View more
  28 in total

1.  Identification of functionally important domains in the N-terminal region of telomerase reverse transcriptase.

Authors:  J Xia; Y Peng; I S Mian; N F Lue
Journal:  Mol Cell Biol       Date:  2000-07       Impact factor: 4.272

2.  Characterization of the interaction between the nuclease and reverse transcriptase activity of the yeast telomerase complex.

Authors:  H Niu; J Xia; N F Lue
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

3.  Telomerase-associated protein TEP1 is not essential for telomerase activity or telomere length maintenance in vivo.

Authors:  Y Liu; B E Snow; M P Hande; G Baerlocher; V A Kickhoefer; D Yeung; A Wakeham; A Itie; D P Siderovski; P M Lansdorp; M O Robinson; L Harrington
Journal:  Mol Cell Biol       Date:  2000-11       Impact factor: 4.272

4.  A conserved telomerase motif within the catalytic domain of telomerase reverse transcriptase is specifically required for repeat addition processivity.

Authors:  Neal F Lue; You-Chin Lin; I Saira Mian
Journal:  Mol Cell Biol       Date:  2003-12       Impact factor: 4.272

5.  Human telomerase contains two cooperating telomerase RNA molecules.

Authors:  C Wenz; B Enenkel; M Amacker; C Kelleher; K Damm; J Lingner
Journal:  EMBO J       Date:  2001-07-02       Impact factor: 11.598

6.  Specific telomerase RNA residues distant from the template are essential for telomerase function.

Authors:  J Roy; T B Fulton; E H Blackburn
Journal:  Genes Dev       Date:  1998-10-15       Impact factor: 11.361

7.  The reverse transcriptase component of the Tetrahymena telomerase ribonucleoprotein complex.

Authors:  K Collins; L Gandhi
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-21       Impact factor: 11.205

8.  Telomerase catalysis: a phylogenetically conserved reverse transcriptase.

Authors:  V Lundblad
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-21       Impact factor: 11.205

9.  Developmentally programmed assembly of higher order telomerase complexes with distinct biochemical and structural properties.

Authors:  E C Greene; D E Shippen
Journal:  Genes Dev       Date:  1998-09-15       Impact factor: 11.361

10.  Expression of mouse telomerase catalytic subunit in embryos and adult tissues.

Authors:  L Martín-Rivera; E Herrera; J P Albar; M A Blasco
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.